science wire
« BACK
Career - Health - 17.10.2019
Computer Science / Telecom - Health - 17.10.2019
Health - 17.10.2019
Health - Chemistry - 17.10.2019
Pharmacology - Health - 16.10.2019
Health - Life Sciences - 16.10.2019
Health - 16.10.2019
Health - Social Sciences - 16.10.2019
Health - 16.10.2019
Health - 15.10.2019
Health - 15.10.2019
Life Sciences - Health - 15.10.2019
Career - Health - 15.10.2019
Health - 14.10.2019
Life Sciences - Health - 14.10.2019
Health - Pharmacology - 14.10.2019
Pharmacology - Health - 14.10.2019
Health - 11.10.2019
Health - Life Sciences - 11.10.2019
Health - Life Sciences - 11.10.2019
Sport - Health - 10.10.2019
Health - Pharmacology - 10.10.2019
Pharmacology - Health - 10.10.2019
Health - 10.10.2019
Pharmacology - Health - 09.10.2019
Pharmacology - Health - 09.10.2019
Health - 08.10.2019
Health - 08.10.2019
Health - Life Sciences - 08.10.2019
Pharmacology - Health - 08.10.2019
Pharmacology - Health - 08.10.2019
Veterinary Science - Health - 08.10.2019
Administration - Health - 07.10.2019
Health - Pharmacology - 07.10.2019
Health - 07.10.2019
Health - 07.10.2019
Life Sciences - Health - 04.10.2019
Health - Life Sciences - 04.10.2019
Health - Life Sciences - 04.10.2019
Sport - Health - 04.10.2019
Health - Business / Economics - 03.10.2019
Health - Pharmacology - 03.10.2019
Environment - Health - 02.10.2019
Health - 02.10.2019
Health - Pharmacology - 02.10.2019
Pharmacology - Health - 02.10.2019
Pharmacology - Health - 01.10.2019
Life Sciences - Health - 01.10.2019
Health - 01.10.2019
Health - History / Archeology - 01.10.2019
Health
Results 151 - 200 of 18754.
Shawn Brown Selected as the Director of the Pittsburgh Supercomputing Center
Shawn Brown has been selected as the next director of the Pittsburgh Supercomputing Center (PSC) , a joint research center of Carnegie Mellon University and the University of Pittsburgh.
Shawn Brown has been selected as the next director of the Pittsburgh Supercomputing Center (PSC) , a joint research center of Carnegie Mellon University and the University of Pittsburgh.
E-cigarettes may help over 50,000 smokers to quit in England each year
A positive link has been found between the number of people in England giving up smoking and the number of people using e-cigarettes to try and quit, according to new UCL-led study. The study, published today in Addiction and funded by Cancer Research UK, found that as use of e-cigarettes in quit attempts went up from 2011 onwards, so did the success rate of quitting.
A positive link has been found between the number of people in England giving up smoking and the number of people using e-cigarettes to try and quit, according to new UCL-led study. The study, published today in Addiction and funded by Cancer Research UK, found that as use of e-cigarettes in quit attempts went up from 2011 onwards, so did the success rate of quitting.
ETH scores highly on interdisciplinarity
Two ETH Zurich projects and one with ETH involvement have been awarded one of the coveted ERC Synergy Grants. These EU grants offer up to EUR 14 million to promote interdisciplinary collaboration on research projects. Correlations and questions in research are becoming more and more complex, which makes collabo-ration between researchers from different fields necessary.
Two ETH Zurich projects and one with ETH involvement have been awarded one of the coveted ERC Synergy Grants. These EU grants offer up to EUR 14 million to promote interdisciplinary collaboration on research projects. Correlations and questions in research are becoming more and more complex, which makes collabo-ration between researchers from different fields necessary.
Hot drinks are the most common cause of burns to young children
New research has shown that hot drink scalds were the commonest cause of children under five presenting to emergency departments, and that only one in four children received adequate first aid before getting to hospital.
New research has shown that hot drink scalds were the commonest cause of children under five presenting to emergency departments, and that only one in four children received adequate first aid before getting to hospital.
Rapid response research centre to predict and prevent global health crises
The world's most advanced institute for disease and emergency analytics is opening in London this week.
The world's most advanced institute for disease and emergency analytics is opening in London this week.
Hot drinks are the most common cause of burns to young children
Parents are being urged to take care with hot drinks as part of a UK-wide campaign to tackle the most common cause of child burns.
Parents are being urged to take care with hot drinks as part of a UK-wide campaign to tackle the most common cause of child burns.
Molecular control of neurotransmitter linked to autism described
Many neurodevelopmental disorders such as epilepsy, schizophrenia, and autism have been linked to disruption of the key neurotransmitter GABA, but the underlying causes of the disruptions have been difficult to pinpoint.
Many neurodevelopmental disorders such as epilepsy, schizophrenia, and autism have been linked to disruption of the key neurotransmitter GABA, but the underlying causes of the disruptions have been difficult to pinpoint.
Stanford encourages employees to review and confirm 2020 medical plan coverage
Stanford is making some changes to its health plan offerings in 2020. Stanford is discontinuing the EPO health plan and adding a new affordable plan, Trio, to the lineup. Stanford Healthcare Alliance members will need to designate a primary care provider.
Stanford is making some changes to its health plan offerings in 2020. Stanford is discontinuing the EPO health plan and adding a new affordable plan, Trio, to the lineup. Stanford Healthcare Alliance members will need to designate a primary care provider.
Organs ’too risky’ to donate may be safer than we think
Detailed infectious virus testing shows potential for increasing organ donation in Australia, by including people previously ineligible due to increased risk of blood-borne viruses, writes Dr Karen Waller and Prof Angela Webster.
Detailed infectious virus testing shows potential for increasing organ donation in Australia, by including people previously ineligible due to increased risk of blood-borne viruses, writes Dr Karen Waller and Prof Angela Webster.
Roche’s MabThera/Rituxan (rituximab) superior to mycophenolate mofetil in patients with pemphigus vulgaris
Phase III PEMPHIX study shows Roche's MabThera/Rituxan (rituximab) superior to mycophenolate mofetil in patients with pemphigus vulgaris 40% of patients with pemphigus vulgaris (PV) achieved sustaine
Phase III PEMPHIX study shows Roche's MabThera/Rituxan (rituximab) superior to mycophenolate mofetil in patients with pemphigus vulgaris 40% of patients with pemphigus vulgaris (PV) achieved sustaine
Expert second opinion improves reliability of melanoma diagnoses
Getting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist's visual assessment of biopsy material on microscopic slides, which can often be subjective.
Getting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist's visual assessment of biopsy material on microscopic slides, which can often be subjective.
ERC Synergy Grant for research at the interface of viral infection and cellular regulation
The European Research Council has awarded one of the prestigious ERC Synergy Grants - the most competitive funding scheme from ERC - to a joint research project of the Friedrich Miescher Institute for Biomedical Research, the ETH Zurich and the University of Bristol. The interdisciplinary team wants to investigate the molecular mechanisms of viral infection, which will contribute to fundamental knowledge about cellular regulation and new concepts for broad-spectrum anti-viral therapy.
The European Research Council has awarded one of the prestigious ERC Synergy Grants - the most competitive funding scheme from ERC - to a joint research project of the Friedrich Miescher Institute for Biomedical Research, the ETH Zurich and the University of Bristol. The interdisciplinary team wants to investigate the molecular mechanisms of viral infection, which will contribute to fundamental knowledge about cellular regulation and new concepts for broad-spectrum anti-viral therapy.
ERC Synergy Grant for viral infection and cellular regulation research
The European Research Council has awarded one of the prestigious ERC Synergy Grants - the most competitive funding scheme from ERC - to a joint research project of the Friedrich Miescher Institute for Biomedical Research, the ETH Zurich and the University of Bristol. The interdisciplinary team wants to investigate the molecular mechanisms of viral infection, which will contribute to fundamental knowledge about cellular regulation and new concepts for broad-spectrum anti-viral therapy.
The European Research Council has awarded one of the prestigious ERC Synergy Grants - the most competitive funding scheme from ERC - to a joint research project of the Friedrich Miescher Institute for Biomedical Research, the ETH Zurich and the University of Bristol. The interdisciplinary team wants to investigate the molecular mechanisms of viral infection, which will contribute to fundamental knowledge about cellular regulation and new concepts for broad-spectrum anti-viral therapy.
Digital service launched to help oesophageal cancer patients
A new smart phone app and web portal to help oesophageal cancer patients and their carers understand and manage their journey better has been launched today by UCL, University College London Hospital (UCLH) and digital health company, Living With.
A new smart phone app and web portal to help oesophageal cancer patients and their carers understand and manage their journey better has been launched today by UCL, University College London Hospital (UCLH) and digital health company, Living With.
Sixth patient receives pioneering treatment for CJD
A sixth patient is receiving a new drug for Creutzfeldt-Jakob disease (CJD) developed by researchers at the Medical Research Council (MRC) Prion Unit at UCL.
A sixth patient is receiving a new drug for Creutzfeldt-Jakob disease (CJD) developed by researchers at the Medical Research Council (MRC) Prion Unit at UCL.
CDC Funds Carnegie Mellon’s Flu Forecasting Center
Center of Excellence Will Develop Tools for Forecasting Epidemics and Pandemics The U.S. Centers for Disease Control and Prevention has named Carnegie Mellon University as an Influenza
Center of Excellence Will Develop Tools for Forecasting Epidemics and Pandemics The U.S. Centers for Disease Control and Prevention has named Carnegie Mellon University as an Influenza
Q&A: Educating children about health risks of vaping
The number of teens who use electronic cigarettes, or vape, is at an all-time high, and there's growing concern that vaping can cause severe lung illness and injury, as well as an addiction to nicotine. Additionally, several deaths have been attributed to vaping-related illnesses, and that number continues to grow, according to the Centers for Disease Control and Prevention.
The number of teens who use electronic cigarettes, or vape, is at an all-time high, and there's growing concern that vaping can cause severe lung illness and injury, as well as an addiction to nicotine. Additionally, several deaths have been attributed to vaping-related illnesses, and that number continues to grow, according to the Centers for Disease Control and Prevention.
Prostate cancer research, important SNF grant goes to the IOR
The Prostate cancer biology Group, led by Dr. Giuseppina Carbone at the Institute of Oncology Research (IOR, affiliated to USI Universitą della Svizzera italiana), has received a 4-year grant
The Prostate cancer biology Group, led by Dr. Giuseppina Carbone at the Institute of Oncology Research (IOR, affiliated to USI Universitą della Svizzera italiana), has received a 4-year grant
Novartis receives FDA approval for Beovu , offering wet AMD patients vision gains and greater fluid reductions vs aflibercept
In two head-to-head clinical trials, patients on Beovu (brolucizumab) achieved vision gains that were non-inferior to aflibercept at year one with longer treatment intervals in a majority of patients
In two head-to-head clinical trials, patients on Beovu (brolucizumab) achieved vision gains that were non-inferior to aflibercept at year one with longer treatment intervals in a majority of patients
Scientists awarded £1.25 million to study antimicrobial use and resistance in Argentinian farms
What drives the risks of antimicrobial resistance in Argentinian livestock farms' How can these risks be minimised through effective regulation?
What drives the risks of antimicrobial resistance in Argentinian livestock farms' How can these risks be minimised through effective regulation?
Berkeley Talks transcript: Nobel laureate Randy Schekman on new Parkinson’s research
Intro: This is Berkeley Talks , a Berkeley News podcast that features lectures and conversations that happen at UC Berkeley. Find more talks at news.berkeley.edu/podcasts, and you can subscribe on Apple Podcasts or wherever you listen. George Brooks: Randy Wayne Schekman was born in Saint Paul, Minnesota.
Intro: This is Berkeley Talks , a Berkeley News podcast that features lectures and conversations that happen at UC Berkeley. Find more talks at news.berkeley.edu/podcasts, and you can subscribe on Apple Podcasts or wherever you listen. George Brooks: Randy Wayne Schekman was born in Saint Paul, Minnesota.
Nobel laureate Randy Schekman on new Parkinson’s research
Read the transcript. Subscribe to Berkeley Talks. Randy Schekman, a professor of molecular and cell biology at UC Berkeley and winner of the 2013 Nobel Prize in physiology or medicine, spoke at the Aging, Research and Technology Innovation Summit on Sept. 17. (UC Berkeley photo by Elena Zhukova) On Sept.
Read the transcript. Subscribe to Berkeley Talks. Randy Schekman, a professor of molecular and cell biology at UC Berkeley and winner of the 2013 Nobel Prize in physiology or medicine, spoke at the Aging, Research and Technology Innovation Summit on Sept. 17. (UC Berkeley photo by Elena Zhukova) On Sept.
Wireless pain management could be alternative to opioids
Rice neuroengineers developing implantable nerve stimulators for project By Graciela Gutierrez Special to the Rice News Neuroengineers at Rice University and the Texas Medical Center are teaming up t
Rice neuroengineers developing implantable nerve stimulators for project By Graciela Gutierrez Special to the Rice News Neuroengineers at Rice University and the Texas Medical Center are teaming up t
Tran Overcomes Setback, Engineers Final Year of Football, Master’s Degree
Heart surgery couldn't sack Long Tran. Tran, a defensive end for the Carnegie Mellon University Tartans , returned to the starting lineup last year after sitting out the 2017 season following heart surgery to stop premature ventricular contractions, or extra, abnormal heartbeats.
Heart surgery couldn't sack Long Tran. Tran, a defensive end for the Carnegie Mellon University Tartans , returned to the starting lineup last year after sitting out the 2017 season following heart surgery to stop premature ventricular contractions, or extra, abnormal heartbeats.
New partnership aims to identify new disease mechanisms and potential targets for treatment of non-alcoholic fatty liver disease
A new partnership between scientists at the University of Birmingham and global healthcare company Novo Nordisk aims to discover new treatments for people suffering from fatty liver disease.
A new partnership between scientists at the University of Birmingham and global healthcare company Novo Nordisk aims to discover new treatments for people suffering from fatty liver disease.
Environmental cost of formula milk needs global attention, argue scientists
Support for breastfeeding is an environmental imperative, argue experts from Imperial College London.
Support for breastfeeding is an environmental imperative, argue experts from Imperial College London.
Immune cells in the spotlight
How do immune cells behave in the body? What happens during immunotherapy, which is designed to encourage the body's own immune system to attack a disease? To answer these questions, the European Union (EU) brings together leading experts from research and the pharmaceutical industry.
How do immune cells behave in the body? What happens during immunotherapy, which is designed to encourage the body's own immune system to attack a disease? To answer these questions, the European Union (EU) brings together leading experts from research and the pharmaceutical industry.
Novartis positive 52-week PREVENT data confirm Cosentyx efficacy in addressing entire axSpA spectrum
Phase III PREVENT study met 52-week primary endpoint of ASAS40, showing a sustained response in patients with non-radiographic axial spondyloarthritis (nr-axSpA) Novartis plans FDA submission for nr-axSpA, having submitted to EMA previously.
Phase III PREVENT study met 52-week primary endpoint of ASAS40, showing a sustained response in patients with non-radiographic axial spondyloarthritis (nr-axSpA) Novartis plans FDA submission for nr-axSpA, having submitted to EMA previously.
Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence
Multiyear alliance underpins the Novartis commitment to leverage data & Artificial Intelligence (AI) to transform how medicines are discovered, developed and commercialized Novartis to establish
Multiyear alliance underpins the Novartis commitment to leverage data & Artificial Intelligence (AI) to transform how medicines are discovered, developed and commercialized Novartis to establish
Three UC San Diego Researchers Receive Top Honors with NIH Director’s Awards
Rob Knight, PhD, awarded the Pioneer Award; Omar Akbari, PhD, and Shadi Dayeh, PhD, receive the New Innovator Award, recognizing innovative approaches to biomedical research Three University of Calif
Rob Knight, PhD, awarded the Pioneer Award; Omar Akbari, PhD, and Shadi Dayeh, PhD, receive the New Innovator Award, recognizing innovative approaches to biomedical research Three University of Calif
New art exhibition explores strange history of dentistry and its links to Birmingham Jewellery Quarter
An exhibition will open at a gallery at Birmingham Dental Hospital and the University of Birmingham School of Dentistry investigating the link between teeth and the city's historic Jewellery Quarter.
An exhibition will open at a gallery at Birmingham Dental Hospital and the University of Birmingham School of Dentistry investigating the link between teeth and the city's historic Jewellery Quarter.